IL23A and breast carcinoma: Statistics from the Kaplan–Meier plotter database (https://www.kmplot.com) revealed that higher expression of IL23A was correlated with better overall survival in patients with breast cancer (HR = 0.73, P = 0.0048) (Fig. 1H, left panel).